Variability of CT Airways Measurements in COPD Patients Between Morning and Afternoon: Comparisons to Variability of Spirometric Measurements.

[1]  P. Gevenois,et al.  Effect of total lung capacity, gender and height on CT airway measurements. , 2017, The British journal of radiology.

[2]  K. Tatsumi,et al.  Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression? , 2017, International journal of chronic obstructive pulmonary disease.

[3]  Yoichi M. Ito,et al.  Computed tomography (CT)-assessed bronchodilation induced by inhaled indacaterol and glycopyrronium/indacaterol in COPD. , 2016, Respiratory medicine.

[4]  Vincent Ninane,et al.  Chronic Obstructive Pulmonary Disease: CT Quantification of Airway Dimensions, Numbers of Airways to Measure, and Effect of Bronchodilation. , 2015, Radiology.

[5]  J. Leipsic,et al.  Qualitative and Quantitative Assessment of Smoking-related Lung Disease: Effect of Iterative Reconstruction on Low-dose Computed Tomographic Examinations , 2014, Journal of thoracic imaging.

[6]  David A Lynch,et al.  Quantitative Computed Tomography in Chronic Obstructive Pulmonary Disease , 2013, Journal of thoracic imaging.

[7]  Carla G. Wilson,et al.  Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. , 2013, AJR. American journal of roentgenology.

[8]  L. Edwards,et al.  Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD. , 2013, Respiratory medicine.

[9]  D. Gierada,et al.  Accurate measurement of small airways on low-dose thoracic CT scans in smokers. , 2013, Chest.

[10]  M. Oudkerk,et al.  Morphological measurements in computed tomography correlate with airflow obstruction in chronic obstructive pulmonary disease: systematic review and meta-analysis , 2012, European Radiology.

[11]  Ella A. Kazerooni,et al.  CT-based Biomarker Provides Unique Signature for Diagnosis of COPD Phenotypes and Disease Progression , 2012, Nature Medicine.

[12]  Nicola A Hanania,et al.  Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. , 2011, Radiology.

[13]  Edwin K Silverman,et al.  Chronic obstructive pulmonary disease phenotypes: the future of COPD. , 2010, American journal of respiratory and critical care medicine.

[14]  A. Gulsvik,et al.  Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking , 2009, European Respiratory Journal.

[15]  Y. Nakano,et al.  Longitudinal study of airway dimensions in chronic obstructive pulmonary disease using computed tomography , 2008, Respirology.

[16]  David P. Naidich,et al.  Boundary-Specific Cost Functions for Quantitative Airway Analysis , 2007, MICCAI.

[17]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[18]  T. Honda,et al.  Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high‐resolution computed tomography , 2006, Respirology.

[19]  T. Honda,et al.  Characteristics of COPD phenotypes classified according to the findings of HRCT. , 2006, Respiratory medicine.

[20]  M. Hasegawa,et al.  Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[21]  Robert Wise,et al.  Predictors of mortality in patients with emphysema and severe airflow obstruction. , 2006, American journal of respiratory and critical care medicine.

[22]  Yasutaka Nakano,et al.  The prediction of small airway dimensions using computed tomography. , 2005, American journal of respiratory and critical care medicine.

[23]  P. Calverley,et al.  Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease , 2003, Thorax.

[24]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[25]  P. Paré,et al.  Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. , 2000, American journal of respiratory and critical care medicine.

[26]  J. Wedzicha.  The heterogeneity of chronic obstructive pulmonary disease , 2000, Thorax.

[27]  H A Vrooman,et al.  A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. , 1999, American journal of respiratory and critical care medicine.

[28]  J. Roca,et al.  Standardization of the measurement of transfer factor (diffusing capacity) , 1993, European Respiratory Journal.

[29]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[30]  P H Nath,et al.  Detection of emphysema with computed tomography. Correlation with pulmonary function tests and chest radiography. , 1988, Investigative radiology.

[31]  P. Gevenois,et al.  Effect of total lung capacity and gender on CT densitometry indexes. , 2016, The British journal of radiology.

[32]  Christoph Düber,et al.  Accuracy of automatic airway morphometry in computed tomography-correlation of radiological-pathological findings. , 2012, European journal of radiology.

[33]  J. Boone,et al.  Size-Specific Dose Estimates (SSDE) in Pediatric and Adult Body CT Examinations , 2011 .

[34]  R. A. Fisher,et al.  Statistical Tables for Biological, Agricultural and Medical Research , 1956 .